Bone Marrow-derived Dendritic Cell (BMDC) Preparation
3:25
T Cell Syngeneic Proliferation Assay
7:26
Results: Representative Tolerogenic DC (TolDC) Analyses
8:53
Conclusion
필기록
The overall goal of this protocol is to develop and characterize murine tolerogenic dendritic cells for the evaluation of their immunotherapeutic utility in the treatment of autoimmune disorders, such as multiple sclerosis. This method can help an
이 콘텐츠에 액세스하려면 로그인하거나 무료 평가판을 시작하세요
Here, we present a protocol to develop and characterize tolerogenic dendritic cells (TolDCs) and evaluate their immunotherapeutic utility.